Jazz Pharmaceuticals JAZZ Goodwill Foreign Currency Translation Gain Loss
Goodwill Foreign Currency Translation Gain Loss at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's goodwill foreign currency translation gain loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's goodwill foreign currency translation gain loss?
- Jazz Pharmaceuticals (JAZZ) reported goodwill foreign currency translation gain loss of -$24.3M in Q1 2026.
- How has Jazz Pharmaceuticals's goodwill foreign currency translation gain loss changed year-over-year?
- Jazz Pharmaceuticals's goodwill foreign currency translation gain loss decreased by 155.6% year-over-year, from $43.72M to -$24.3M.
- What does goodwill foreign currency translation gain loss mean?
- Impact of currency exchange rate changes on financial reporting.
- How do you interpret goodwill foreign currency translation gain loss?
- Gains indicate a favorable currency environment for the company's international footprint, while losses indicate a negative impact from foreign exchange volatility.
- How does goodwill foreign currency translation gain loss compare across companies?
- Common for multinational corporations with significant operations outside their home currency jurisdiction.